Venclexta 10 mg/1 (Venetoclax TABLET, FILM COATED) 10 mg/1

Venclexta 10 mg tablets are a medication used to treat certain types of blood cancers. This oral treatment is designed to target specific cells in the body, offering a targeted approach to cancer therapy.

Strength

10 mg/1

Pack Size

1 BLISTER PACK in 1 CARTON (0074-0561-11) / 2 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Venclexta 10 mg tablets are primarily used in the treatment of chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Venetoclax, the active ingredient, works by targeting and destroying cancer cells. This medication is often used in combination with other treatments to enhance its effectiveness. Patients should consult their healthcare provider to determine if Venclexta is suitable for their specific condition.

Side Effects

Common effects of Venclexta 10 mg tablets may include fatigue, nausea, and diarrhea. Some patients may experience low blood cell counts, which can increase the risk of infections or bleeding. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Precautions & Warnings

Venclexta 10 mg tablets should be handled with care, as they are specifically designed for oral use. Patients should follow their healthcare provider's instructions for administration and storage. It is crucial to inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Venclexta 10 mg tablets may interact with certain medications, including those that affect liver enzymes. Alcohol and other substances that affect liver function should be avoided. Patients should discuss all current medications with their healthcare provider to ensure safe and effective use of Venclexta.

Frequently Asked Questions

Venclexta is used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML).

Venclexta is taken orally, typically as directed by a healthcare provider. Patients should follow their specific dosage instructions carefully.

Common side effects may include fatigue, nausea, diarrhea, and low blood cell counts. Patients should report any unusual symptoms to their healthcare provider.

Venclexta may interact with certain medications, especially those that affect liver enzymes. Patients should discuss all current medications with their healthcare provider.

Patients should follow their healthcare provider's instructions for administration and storage. It is important to inform your healthcare provider about any other medications you are taking.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.